Immunization Clinical Trial
— MINTOfficial title:
mHealth-Assisted Conditional Cash Transfers to Improve Timeliness of Childhood Vaccinations
Verified date | June 2020 |
Source | Duke University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Vaccination is a cost-effective strategy for conferring immunity against a host of preventable diseases, however, rates of timely childhood vaccinations remain inadequate in resource-limited settings. We propose to evaluate the feasibility and efficacy of mHealth-assisted conditional cash transfers as a means of overcoming individual barriers to timely vaccinations. The study will form the basis for a pragmatic randomized controlled trial of the efficacy and cost-effectiveness of mHealth reminders and conditional cash transfers for improving rates of timely vaccinations among young children.
Status | Completed |
Enrollment | 412 |
Est. completion date | December 31, 2018 |
Est. primary completion date | October 13, 2018 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 16 Years and older |
Eligibility |
Inclusion Criteria: - Pregnant, last trimester - Access to mobile phone Exclusion Criteria: - Cognitive impairment - Unwillingness to receive study-related information and reminders via mobile phone |
Country | Name | City | State |
---|---|---|---|
Tanzania | National Institute for Medical Research | Dar es Salaam |
Lead Sponsor | Collaborator |
---|---|
Duke University | John E. Fogarty International Center (FIC), National Institute for Medical Research, Tanzania, University of South Carolina |
Tanzania,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Timely vaccination visits | Number of vaccination visits within 4 weeks of scheduled visit dates | Up to 6 months after birth | |
Secondary | Number of vaccinations received | Number of vaccinations received | Up to 6 months after birth | |
Secondary | Number of timely vaccinations received | Number of vaccinations received within 4 weeks of scheduled vaccination dates | Up to 6 months after birth |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02526394 -
Pertussis and Meningitis C Concomitant Vaccination in Adolescents
|
Phase 4 | |
Completed |
NCT01707212 -
Prenatal Education About Infant Immunization Pain Management
|
Phase 3 | |
Completed |
NCT01463176 -
Music Therapy as Procedural Support for Young Children Undergoing Immunizations
|
N/A | |
Completed |
NCT01193335 -
Study Evaluating a 13-valent Pneumococcal Conjugate Vaccine in Preterm Compared to Term Infants.
|
Phase 4 | |
Completed |
NCT04222595 -
FluPRINT Study: Characterisation of the Immune and Transcriptional Response to LAIV
|
N/A | |
Completed |
NCT05794113 -
Comparing the Use of a Mobile App for Surveillance of Adverse Events Following Influenza Immunization to a Web-Based Platform
|
N/A | |
Recruiting |
NCT01713322 -
Testing Educational Materials in a Paediatric Setting
|
Phase 3 | |
Not yet recruiting |
NCT03705455 -
Immunization Schedule Alert Platform
|
N/A | |
Recruiting |
NCT01601197 -
A Study of Two Injection Techniques to Reduce Pain in Infants Undergoing Immunization
|
Phase 3 | |
Completed |
NCT01296906 -
Population Versus Practice-based Interventions to Increase Immunizations
|
N/A | |
Completed |
NCT01399814 -
Restricted Intravenous Fluid Regime Effects on Immunological Indicators of Elderly Patients Operated for Abdominal Cancer
|
Phase 3 | |
Completed |
NCT01390363 -
Study of Adolescent Immunization Recall Systems
|
N/A | |
Completed |
NCT02609035 -
Immunization Services Model for Adult Rate Improvement
|
N/A | |
Recruiting |
NCT02200276 -
Influenza Immunization in Adults Over Age 75
|
N/A | |
Completed |
NCT01677702 -
Study of Yili Lactoferrin ShuHua Milk in the Improvement of Human Immunization
|
N/A | |
Recruiting |
NCT05213000 -
Adjuvant Effect of Physical Exercise on Immune Response to COVID-19 Vaccination and Interactions With Stress
|
N/A | |
Completed |
NCT03188692 -
Safety and Efficacy of BK1310 Intramuscular Injection in Healthy Infants
|
Phase 3 | |
Completed |
NCT02432430 -
Comparison of Immunization Quality Improvement Dissemination Study
|
N/A | |
Completed |
NCT01379846 -
Study of TAK-816 in Healthy Infants
|
Phase 3 | |
Active, not recruiting |
NCT03943875 -
GARDASIL 9: 3 Dose vs. 2 Dose With Delayed 3rd Dose
|
Phase 4 |